C20 Sphingomyelin (d18:1/20:1)

C20 Sphingomyelin (d18:1/20:1) (Compound SM:20:1) is a sphingomyelin. C20 Sphingomyelin (d18:1/20:1) is promising for research of motor neuron diseases such as amyotrophic lateral sclerosis (ALS) and primary lateral sclerosis (PLS) [1].

Product Specifications

CAS Number

[222403-67-0]

UNSPSC

12352211

Target

Liposome

Related Pathways

Metabolic Enzyme/Protease

Applications

Neuroscience-Neurodegeneration

Field of Research

Neurological Disease

Smiles

CCCCCCCC/C=C\CCCCCCCCCC(N[C@H]([C@H](O)/C=C/CCCCCCCCCCCCC)COP(OCC[N+](C)(C)C)([O-])=O)=O

Molecular Formula

C43H85N2O6P

Molecular Weight

757.12

References & Citations

[1]Area-Gomez E, et al. Lipidomics study of plasma from patients suggest that ALS and PLS are part of a continuum of motor neuron disorders. Sci Rep. 2021 Jun 30;11 (1) :13562.